Other News

ARCA Biopharma Announces First Quarter 2019 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., May 08, 2019 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported financial results for the quarter ended March 31, 2019 and provided a corporate update. “In the first part of this year, we […]

Philips announces collaboration with Medtronic to further advance the image-guided treatment of atrial fibrillation

May 9, 2019 Philips’ integrated solution will combine the unique KODEX-EPD dielectric imaging and navigation system, dielectric imaging sensors, clinical software, and services to support cryoablation procedures performed with the Medtronic Arctic Front Advance™ cryoablation technology Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced a collaboration with Medtronic to further advance […]

Duration of External ECG Monitoring is Critical to Detecting Atrial Fibrillation

MINNEAPOLIS, May 9, 2019 /PRNewswire/ — Preventice Solutions announced today the presentation of data showing the critical impact the length of the monitoring period has when using ambulatory remote ECG monitoring to detect atrial fibrillation (AF). While the Preventice BodyGuardian® Remote Monitoring System has the capability and reimbursement to support patient monitoring for […]

Acutus Medical Expands AFib Offerings; Announces Strategic Acquisition and New Partnerships in Monitoring and Therapy

SAN FRANCISCO, May 9, 2019 /PRNewswire/ — Today at the 40th annual Heart Rhythm Scientific Sessions, Acutus Medical announced the agreement to acquire Rhythm Xience, Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus’ expanded portfolio builds on the organization’s unprecedented mapping and visualization technology platform. Acutus is committed to helping […]

Stereotaxis and Osypka Enter Strategic Collaboration to Advance Robotic Catheter Technology

Development of next generation robotically-navigated magnetic ablation catheter fully owned by Stereotaxis Catheter designed to enhance patient care, improve therapy delivery, simplify catheter navigation, and strengthen commitment to open ecosystem Entered into additional business agreements to support a long-term broad collaboration in electrophysiology ST. LOUIS and RHEINFELDEN, Germany, May 09, […]

BIOSENSE WEBSTER ANNOUNCES INITIAL RESULTS FROM FIRST IN-HUMAN STUDY OF NOVEL HIGH POWER-SHORT DURATION ABLATION CATHETER FOR ATRIAL FIBRILLATION

Researchers Report QDOT MICRO Radiofrequency Ablation Catheter Demonstrates Safety and Achieves Pulmonary Vein Isolation with Shorter Procedure and Fluoroscopy Times SAN FRANCISCO — May 9, 2019 – Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s QDOT MICRO, a novel catheter that facilitates high power-short duration radiofrequency […]

Corindus Reports First Quarter 2019 Results

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ended March 31, 2019. Recent Financial Highlights and Business Accomplishments: Revenue totaled $3.0 million during the first quarter of 2019, including sale and installation of nine […]

Murj Announces the Future of Cardiac Device Analytics

SANTA CRUZ, Calif., May 08, 2019 (GLOBE NEWSWIRE) — Murj, the digital healthcare company for Software-as-a-Service (SaaS) cardiac implantable electronic device (CIED) management announced today the availability of Murj Analytics. This new offering features powerful intelligence for cardiac device clinicians seeking to provide comprehensive population management through improved clinical, workforce […]

Proteon Therapeutics Announces First Quarter 2019 Financial Results

WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced its financial results for the quarter ended March 31, 2019, and recent events. Recent Events PATENCY-2 Trial Misses Statistical […]

MyoKardia Announces Inaugural MyoSeeds™ Research Grants Program Awardees

SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) — MyoKardia, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of serious cardiovascular diseases, today announced the award of $750,000 divided among three innovative research projects through the first cycle of its MyoSeeds™ Research Grants Program (“MyoSeeds”).  MyoSeeds is […]